← Eichor
Condition: Gbs Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gbs

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Preparing for Maternal GBS Vaccine Trials in Africa
Phase N/A · 10 location(s) · Barcelona Institute for Global Health · NCT06833957Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome
NA · 2 location(s) · Assiut University · NCT06996509Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Phase N/A · 1 location(s) · University of Ulm · NCT04871035Cohort Study on Neuroimmune Diseases in the Reproductive Age
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT07653984Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT04829526Genomics and COVID-19 Vaccine Adverse Events
Phase N/A · 1 location(s) · University of British Columbia · NCT05212792Living With Guillain-Barré Syndrome as Children.
Phase N/A · 2 location(s) · University Hospital, Toulouse · NCT06940908An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barr
Phase 3 · 13 location(s) · Annexon, Inc. · NCT07020819Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic
Phase N/A · 1 location(s) · Assiut University · NCT06615622
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.